Sell-side Taking Aim at Shares of Molina Healthcare Inc (NYSE:MOH)

Sell-side Taking Aim at Shares of Molina Healthcare Inc (NYSE:MOH)

Nellie Chapman
|
17 February, 2017, 01:18

8 Analysts reported that the Price Target for Molina Healthcare, Inc. might touch $68 high while the Average Price Target and Low price Target is $58.69 and $48 respectively. They set an "overweight" rating and a $65.00 price objective for the company. Analysts have a mean recommendation of 2.80 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Goldman Analysts lifted the stock to Buy from Neutral. The current consensus estimate compares to last year's same quarter result of $0.7 a share and an increase of 7.14%. The company reported ($1.54) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.75 by $2.29. Using all the ratings on Molina Healthcare Inc (NYSE:MOH), the mean rests at 2.5.

The number of Molina Healthcare shares in issue is 56,820,000 which have a current share price of 59.89 bringing Molina Healthcare's market capitalisation to 3.40B United States dollars.

8 analysts polled by Zacks Research now have a mean target price of $59 on Molina Healthcare Inc (NYSE:MOH). It has been assigned a low target price of $50 and a high target price of $78.

Molina Healthcare, Inc. (NYSE:MOH), stock is trading $67.87 above the 52-week high and has displayed a high EPS growth of 14.10% in last 5 years. Molina Healthcare had a net margin of 0.76% and a return on equity of 9.38%. The consensus rating is 2.6, suggesting the market has given up on the stock. Sell-side analyst recommendations point to a short term price target of $60.58 on the company shares. The original version of this report can be accessed at https://www.com-unik.info/2017/02/16/molina-healthcare-inc-moh-stock-rating-reaffirmed-by-jefferies-group-llc.html. On average, equities research analysts forecast that Molina Healthcare will post $2.79 EPS for the current year.

In other Molina Healthcare news, Director Charles Z. Fedak sold 4,875 shares of the firm's stock in a transaction on Wednesday, November 30th. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. Hsbc Holdings PLC now owns 4,962 shares of the company's stock worth $290,000 after buying an additional 23 shares during the period. It is predicted to add 6% on day 1 and jump 7% on day 7 after the company reports upcoming earnings. Following the completion of the sale, the director now directly owns 28,096 shares of the company's stock, valued at $1,490,773.76. Algert Global LLC raised its position in shares of Molina Healthcare by 0.8% in the third quarter. ETRADE Capital Management LLC acquired a new position in shares of Molina Healthcare during the third quarter worth about $259,000. Hedge funds and other institutional investors own 89.61% of the company's stock. The Company operates through two segments: Health Plans segment and Molina Medicaid Solutions segment. Its Health Plans segment consists of health plans in approximately 10 states and the Commonwealth of Puerto Rico, and its direct delivery business.